Loading decisions…
Loading decisions…
16,110 vetted Board decisions for Prostate cancer.
The Board has granted service connection for the Veteran's prostate cancer, impotency as secondary to prostate cancer, and incontinence as secondary to prostate cancer. The Board found that his prostate cancer is related to his exposure to contaminated water at Camp Lejeune during service.
The Board found that the reduction of the Veteran's prostate cancer disability rating from 100% to 20% was proper and denied a higher rating for prostate cancer.
The Board denied service connection for the cause of the Veteran's death, finding that there is no medical evidence supporting a nexus between his childhood diptheria and heart failure.
The Veteran's claims for higher ratings for coronary artery disease, colon cancer residuals, and prostate cancer residuals are being remanded due to a duty to assist error. The VA needs to obtain the Veteran's private treatment records from Dr. M.T. and clarify whether his prostate cancer was active and if he was receiving any current treatment.
The Board denied the Veteran's claim for service connection for prostate cancer, finding that there is not a relationship between his in-service prostatitis and his current prostate cancer. The Board also denied the TDIU claim.,The evidence did not support a nexus between the Veteran's service-connected prostatitis and his diagnosed prostate cancer.
The Board has granted a 40 percent rating for prostate cancer with voiding dysfunction, effective December 1, 2020. The decision is based on the Veteran's reported symptoms and the VA examination findings.
The Veteran's service-connected ischemic heart disease and prostate cancer rendered him unable to secure or follow substantially gainful employment as of July 3, 2019. An effective date of July 3, 2019 is granted for the award of total disability rating based on individual unemployability (TDIU).
The Veteran's prostate cancer residuals disability is granted a rating of 40 percent, but not greater. The ED disability remains noncompensable.
The Veteran's prostate cancer residuals disability is granted a rating of 40 percent, but not greater. The ED disability remains noncompensable.
The Veteran's service-connected disabilities render him unable to secure or follow a substantially gainful occupation, and the Board finds that his TDIU claim is granted.
The Board has decided to remand the claims for neurological disability of the right upper extremity, ganglion cyst of the right wrist, and prostate cancer due to incomplete compliance with previous remands and insufficient rationale provided in the opinions.
The Veteran's claims for service connection for an acquired psychiatric disorder (including PTSD) and prostate cancer are denied. The claim for prostate cancer is remanded due to the need for additional evidence.
The Veteran's claim for an earlier effective date for the grant of service connection for prostate cancer is denied because the first communication expressing intent to file a claim was received on March 14, 2019, which is within one year after his discharge from active service.
The Veteran's spouse, the caregiver, is found to be unable to complete caregiver training within 90 days of applying for PCAFC benefits. The claim is therefore remanded due to a lack of completion of required caregiver training.
The Veteran's claim for service connection for prostate cancer is granted, but the AOJ must verify if he was exposed to herbicide agents aboard the USS Ramsey on July 14, 1968.
The Veteran's prostate cancer, which is presumed to be related to herbicide exposure in Thailand during his service at Ubon Air Force Base, has been granted service connection. This decision is based on the PACT Act of 2022.
The Veteran's prostate cancer is granted service connection due to herbicide agent exposure during his service in Thailand, effective May 25, 2017.
The Veteran's claim for service connection for a respiratory disorder is remanded due to the need for additional development.,The Veteran's claim for service connection for peripheral neuropathy of the lower extremities, secondary to herbicide agent exposure, is remanded due to the need for additional development.,The Veteran's claim for service connection for a neurocognitive disorder, secondary to PTSD, is remanded due to the need for additional development.,The Veteran's claim for an increased rating for prostate cancer residuals is remanded due to the need for additional development.,The Veteran's claim for an effective date earlier than September 23, 2011, for the award of a TDIU is referred to the Director of Compensation and Pension for consideration due to the need for additional development.,The Veteran's claim for special monthly compensation based on the need for aid and attendance is remanded due to the need for additional development.
The Board has determined that additional development is needed for the Veteran's claims of service connection for low back disorder, kidney cancer, colon cancer, and prostate cancer. The Veteran will be afforded VA examinations to determine the nature and etiology of any current diagnoses.
The Board has remanded the Veteran's claims for service connection and increased ratings due to incomplete evaluations, including a lack of consideration of the Veteran's lay statements regarding in-service noise exposure. The claims are being returned for further development.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.